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ABSTRACT 
Objective: The purpose of this work is to examine the protective effect of nanocurcumin and nanochitosan supplementation against potassium 
dichromate toxicity in male mice.  
Methods: Male albino mice weighing 25-30 gm were divided into six groups; the first group received saline. Second and third groups were given 
oral dose of nanocurcumin and nanochitosan respectively for 5 d. Fourth group was injected subcutaneously with a single dose of potassium 
dichromate for 24 h. Group five and six were administrated nanocurcumin and nanochitosan, respectively prior to potassium dichromate. Animals 
were anesthetized by ether anesthesia then bone marrow was harvested for chromosomal examination and epididymal sperms were collected for 
sperm morphology, while Kidneys and testes were collected for western blot and biochemical analysis.  
Results: Potassium dichromate induced significant (P≤0.05) increase in chromosome and sperm abnormalities as well as testicular and renal MDA, 
renal MPO, renal contents of IL-18 and IGF-1, testicular contents of caspase 3 and cytosolic cytochrome c, a reduction in testosterone level, and GPx 
of renal and testicular tissues compared to control group. Pretreatment with both types of nanoparticles showed significant (P≤0.05) mitigation 
against most alterations induced by potassium dichromate; moreover, nanochitosan gave more significant (P≤0.05) improvement against 
chromosome and sperm abnormalities than nanocurcumin.  
Conclusion: The present study revealed that the selected nanoparticles have antioxidant as well as antigenotoxic properties against toxicity of 
potassium dichromate.  
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INTRODUCTION 
Widespread pollution by heavy metals has critical consequences on the 
global public health associated with the quality of the environment and 
able to induce toxicity even at low level of exposure [1-4]. Among those 
toxic heavy metals, chromium is an inorganic environmental pollutant 
which still widely used in many modern industries. It commonly enters 
the environment through the release from these industries into soil and 
water, causing environmental pollutions [5-7]. 
Hexavalent chromium compounds, such as potassium dichromate 
(PDC), is very highly poisonous substance and can induce multiple 
organ toxicity, like nephrotoxicity [8, 9], testicular toxicity [10, 11] 
with negative effects on fertilization [12], aberrations in bone marrow 
and spermatocytes [13], as well as reduced motility of live sperm, and 
sperm death [14]. It can also produce injuries in other organs, 
including liver [15], brain [16], and heart [17]. Many studies have been 
conducted to explore the mechanisms of PDC toxicity on multiple 
aspects, including increased production of reactive oxygen species 
(ROS) [15, 18, 19], inflammation [20], oxidative DNA damage/ 
apoptotic changes [16, 21, 22], genotoxicity/mutagenicity [23, 24], and 
eventually inducing cell damage and death [19].  
Recently, it has been focused on the beneficial role and protective 
effect of phytochemicals on oxidative Stress-mediated testicular 
toxicity and kidney injury [25, 26]. Curcumin (CUR) is main active 
compound in the plant Curcuma longa with several biological activities 
[27, 28]. It has a protective action against several organs’ toxicities 
[29-31]. The pharmacological effects of CUR could attribute to anti-
inflammatory [30, 32], antioxidant [33, 34], anticancer [35] activities. 
Despite numerous therapeutic effects, the bioavailability of CUR is 
relatively low with poor intestinal absorption and aqueous solubility, 
rapid metabolism in the liver and systemic elimination [36-38]. 
Therefore, the nanoformulations of CUR is the most effective tool to 
enhance the water solubility, thereby improving its dispersibility, 
absorption and bioavailability [39, 40].  
Chitosan (CHI) is a modified natural carbohydrate polymer prepared 
by partial N-deacetylation of chitin and popularly used for drug 
delivery formulations. CHI nanoparticles-dependent formulations have 
gained widespread interest as nanoparticles in pharmaceutical drug 
delivery [41, 42], it provides a simple method of preparation and for 
their use in nutritional supplements and nanomedicine applications 
[41, 43] with better stability, low toxicity profile, and the reliability to 
be used as a food ingredient [44]. CHI has an enormous economic and 
medicinal values because of its biological properties. The benefit of 
CHI with respect to its intrinsic antioxidant [45, 46], antimutagenicity 
[47], anti-inflammatory [48] properties have been reported. However, 
as in CUR, the nanoparticle of CHI is more have attracted the attention 
of researchers from different research areas [46, 49].  
In view of the oxidative stress has been associated with PDC-induced 
pathogenesis in numerous organs, the pharmacological use of 
antioxidant supplements as adjuvant therapy could slow or inhibit 
the oxidation by toxic molecules and can be important for cell 
homeostasis. With nanotechnology importance in the improvement 
of the drug physicochemical properties and bioavailability, the main 
aim of the present study was to investigate the protective effect of 
nano CHI and nano CUR particles against the PDC induced toxicity in 
the adult male mice. 
MATERIALS AND METHODS 
Chemicals  
Potassium dichromate was purchased from Sigma chemical 
company (St. Louis, MO). Curcumin and chitosan nanoparticles were 
both prepared by NanoTech Egypt Company for Photo-Electronics 
(Giza, Egypt), and both were characterized by TEM technique (fig. 1). 
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Experiments were performed on thirty six adult male mice (Mus 
musculus), weighing 25-30 gm, were obtained from the Animal 
House Colony of the National Research Centre, Cairo, Egypt and 
housed in polypropylene cages in a temperature-controlled room 
(25±1˚C) under a 12:12 hour light-dark cycle, a relative humidity of 
60±5% and free access to tap water and standard rodent chow with 
the approval of the Ethics Committee of the National Research 
Centre (FWA 00014747) that follows the recommendations of the 
National Institutes of Health Guide for Care and Use of Laboratory 
Animals (publication No. 85-23, revised in 1985). After 2 w of 
acclimation, animals were divided into six groups of six mice each.  
Experimental design  
Group I (control) mice received saline only, while mice in group II 
(CUR) and III (CHI) were treated with 60 mg/Kg, oral dose of 
nanocurcumin and nanochitosan alone, respectively, for 5 
consecutive days [50]. Group IV (PDC) mice were given 
subcutaneous (s. c) injection of potassium dichromate as a single 
dose (15 mg/kg/bw) for 24 h [51]. In group V (CUR+PDC) mice were 
given nanocurcumin first before injected with potassium 
dichromate. Mice in group VI (CHI+PDC) were given nanochitosan 
first before injected with potassium dichromate. At the end of the 
experiment, animals were sacrificed under anesthesia by diethyl 
ether and bone marrow, sperms as well as kidneys and testes were 
separated for the following analysis.  
Chromosomal aberration (CA) assay  
Metaphase chromosomal analysis were performed according to 
Preston et al. [52]. In brief, each mouse 90 min before sacrifice was 
injected intraperitoneally with colchicine (0.04%, 0.1 ml/20g b.w.). 
Bone marrow cells were extracted from femur bones and incubated 
for 20 min at 37 °C in 0.56% KCl hypotonic solution. After 
centrifugation at 1000 rpm for 10 min, cells were collected and fixed 
three times in a freshly prepared solution of methanol: glacial acetic 
acid (3:1, v/v). The cells were dropped on cold slides then stained 
with Giemsa stain for 10 min after it dried. A total of 300 well-spread 
metaphase plates were scored for CA per each group using light 
microscope at a magnification of 1000
Sperm morphology  
×. 
The sperm morphology was evaluated by analysis of sperm smears 
made from cauda epididymis. The prepared slides were fixed in 
absolute methyl alcohol for 15 min then stained with Giemsa stain 
for 10 min. A thousand sperm cells per mouse were assessed for 
morphological abnormalities under oil immersion at 1000×, and 
were classified into three general categories: head, tail, as well as 
head and tail abnormalities [53].  
Preparation of tissue homogenates and protein quantification 
Specimens from kidney and testis were divided into three parts. The 
individual piece was separately weighted and homogenized gently 
with a Potter-Elvenhjem tissue grinder. One part was lysed in [50 
mmol phosphate buffer saline (PBS); pH 7.4] for estimation of 
protein content, testosterone level and MPO activity. The second 
piece was homogenized in [10 mmol potassium phosphate buffer; 
pH 7.4] for estimation of MDA levels and GPx activity, and the third 
part was used for the Western blotting analysis. The crude kidney 
and testicular homogenates were centrifuged at 10,000 rpm for 10 
min at 4 °C, and the resultant supernatant was used for the specific 
assay. Protein content in tissue homogenate was measured 
according to the method Bradford [54], with bovine serum albumin 
(BSA) solution as standard. 
Testosterone levels 
Testosterone levels in the testis of mice [55], with specimens, 
standards, and controls (in triplicates) were prepared to 
manufacturer's instructions by the testosterone HRP-dependent 
immunoassay kit (BioVision Research Products, USA). The 
absorbance was measured at 405 nm on Multiskan®
Oxidative stress status 
 EX microplate 
reader (Thermo Scientific, USA).  
Malondialdehyde (MDA) assay 
The tissue lipid peroxidation (LPO) products were evaluated by 
thiobarbituric acid (TBA) reactive substances (TBARS) in the kidney 
and testis tissues, with the 1,1′,3,3′-tetramethoxypropane was used 
as a standard in constructing the calibration curve [56]. In short, the 
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samples were diluted and proceeded for the acidic reaction while 
heating. After incubation, 2 ml of n-butanol was added to extract the 
resultant pink color. The concentrations of TBA–MDA adducts in 
samples was measured at 535 and 520 nm using spectrophotometer 
(Jenway 6305 UV/VIS, UK).  
Glutathione peroxidase (GPx) activity 
The kidney and testicular GPx activities were measured in the tissue 
homogenates prepared in phosphate buffer using the commercially 
available GPx kit (Biodiagnostic, Egypt) according to the 
manufacturer’s instructions [57]. The changes in absorbance per 
min were measured at 340 nm using spectrophotometer (Jenway 
6305 UV/VIS, UK) against the deionized water as a blank, and the 
GPx activity was expressed at U/mg protein.  
Myeloperoxidase (MPO) activity 
The MPO activity in kidney was assessed using a procedure like that 
recorded previously [58]. In short, homogenized samples [in 50 
mmol phosphate buffer saline, PBS; pH 7.4] were centrifuged for 10 
min at 15000 rpm, and the pellets were then suspended in 50 mmol 
PBS containing 0.5% hexadecyl trimethyl ammonium bromide 
(HETAB). The samples were then mixed, sonicated, and centrifuged 
at 15000 rpm for 10 min before adding to the reaction mixture 
containing 50 mmol PBS, 20 mmol H2O2
Western blot 
, and o-dianisidine. The 
activity of MPO was expressed as U/mg protein, where one unit of 
MPO activity was defined as the amount of the enzyme in samples 
that produced a change in absorbance measured at 460 nm for 3 
min.  
The Western analysis was performed according to previous methods 
[59, 60]. The tissues from kidney and testis were homogenized with 
lysis solution [10 mmol Tris base, 25 mmol ethylene glycol-bis(β-
aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA), 25 mmol 
ethylenediaminetetraacetic acid (EDTA), 100 mmol NaCl, 1.5% (v/v) 
Nonidet P-40 (NP-40), and 1.5% (v/v) Triton X-100; pH 7.4] 
supplemented with 1:500 protease inhibitors, and phosphatase 
inhibitors cocktails (Sigma). Aliquots of the kidney and testicular 
homogenates containing 40 µg proteins were mixed and boiled for 5 
min with 4x sample Loading buffer [12% Sodium Dodecyl Sulphate 
(SDS), 700 mmol Tris-HCl, 600 mmol dithiothreitol (DTT), 60% 
glycerol, and 0.02 % Bromophenol blue; pH 6.8], and allowed to cool 
on ice for 5 min before subjected to 12% SDS-PAGE. The separated 
proteins were transferred electrophoretically from the gels onto 
polyvinylidene fluoride (PVDF) membranes using the Trans-Blot® 
SD semi-dry transfer cell (Biorad, USA). Then, the membranes were 
blocked at RT in TBS buffer [50 mmol Tris-Cl, and 150 mmol NaCl; 
pH 7.4] containing 5% nonfat dry milk (Biorad) for 2 h and 
immediately probed for IL-18 (1:1000 dilution), IGF-1 (1:400 
dilution), cytochrome c (1:300 dilution), caspase-3 (1:250 dilution), 
or β-Actin (1:2000 dilution) at 23-25 °C for 16-18 h. After that, the 
membranes were washed in TBS-T [50 mmol Tris-Cl, and 150 mmol 
NaCl, 0.15% Tween-20; pH 7.4] for 3x10 min and incubated with 
their corresponding HRP-conjugated secondary antibody for 2 h at 
RT. Then, the membranes were washed 3X10 min in TBST and 
exposed to the chemiluminescence Western Lightning ECL (Perkin 
Elmer, Waltham, MA) for 1 min. Blots were visualized in Chemi-Doc 
imager (Biorad), and the bands intensities were then measured with 
normalization the β-Actin, as an internal reference control.  
Statistical analysis 
All data in this study are presented as mean±SD values. GraphPad 
Prism version 7 for Windows (GraphPad Software, San Diego, CA, 
USA) was used for performing statistical analysis. Data were 
analyzed using one-way analysis of variance (ANOVA) with Tukey's 
multiple comparisons test. The difference between groups was 
considered statistically significant when P ≤ 0.05. 
RESULTS 
Chromosomal aberration assay 
Potassium dichromate (PDC) induced high significant level of 
chromosomal aberrations after one day of induction and the 
frequency of total chromosomal abnormalities was 47% compared 
to control 11.7% (table 1). 
  
Table 1: Number and percentage of structural and numerical chromosomal aberrations in mice bone marrow cells of treated groups. Fifty 














aberration (NCA)  
Structural chromosomal aberration (SCA) Groups 
Poly Hyper Hypo dic Pulv Cf Dir. Iso C. 
S 
R Del G Br 
5.83±1.17 3511.7 62 299.7 0 0 6 1 0 6 2 1 8 0 6 3 2 Control 
6±1.41 3612 40.67 3210.67 0 0 4 2 0 4 4 2 6 1 7 2 4 CUR 
4.83±1.94  299.7 40.67 258.33 0 1 3 0 0 5 3 0 7 1 5 1 3 CHI 
23.5±1.87* 14147 4013.33 10133.67 3 8 29 8 12 11 9 5 10 6 20 9 11 PDC 
14.5±1.52*P#$P  8729 144.67 7324.33 0 4 10 5 7 10 8 4 7 4 15 6 7 CUR+PDC 
10.5±2.59*P#$P  6321 113.67 5217.33 1 2 8 4 4 5 7 3 7 3 11 3 5 CHI+PDC 
Data are expressed as mean±SD Statistical analysis was performed for statistical changes between the selected groups: P* P  ≤ 0.05 indicates statistical 
difference from the vehicle-treated (control) group, P#P  ≤ 0.05 indicates statistical difference from the PDC -treated group, and P$P  ≤ 0.05 indicates 
statistical difference between CHI+PDC and CUR+PDC groups in one-way ANOVA test with Tukey's multiple comparisons test. Abbreviations: 
br=break, g=gap, del=deletion, r=ring, cs=centric separation, iso= isochromatid-gap, dir=diradial, Cf=centric fusion, Pulv=pulverization, 
dic=dicentric, Hypo=hypoploidy, Hyper=hyperploidy, Poly=polyploidy. 
 
The different detected types of structural chromosomal aberrations 
were deletion, pulverization, break, centric-fusion, centric-
separation, gap, diradial, dicentric, ring and iso-gap. Moreover, the 
most numerical chromosomal aberrations were in the form of 
hypoploidy (fig. 2A). Curcumin (CUR) or chitosan (CHI) 
nanoparticles does not induced significant difference as compared to 
control group. Pre-treatments with nano CUR or nano CHI before 
PDC injection showed significant reduction in the percentage of total 
chromosomal aberrations. It was noticed that pre-treatment with 
nano CHI gave best results and reduced the chromosomal 
aberrations (21%) significantly compared to nano CUR (29%), fig. 
2B. 
Sperm morphology assay 
Examination of sperms prepared from the control group revealed 
5701 sperm are normal and the remaining sperms (299) were 
deformed. Among these deformed forms are sperms with hook 
deformation, amorphous, big head and abnormal tail, was more 
prevalent. Other types of abnormalities were recorded in rather 
low frequency (table 2). 
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Fig. 2: Chromosomal aberration test. (A) Normal metaphase and different structural and numerical chromosomal aberrations in mice 
bone marrow from metaphases of treated groups. (B) Number of total chromosomal aberrations in the control and treated groups (n=6). 
Data are expressed as mean±SD Statistical analysis was performed for statistical changes between the selected groups: *P ≤ 0.05 indicates 
statistical difference from the vehicle-treated (control) group, #P ≤ 0.05 indicates statistical difference from the PDC-treated group, and $
 
P 
≤ 0.05 indicates statistical difference between CHI+PDC and CUR+PDC groups in one-way ANOVA test with Tukey's multiple comparisons 
test. Abbreviations: CUR, rats treated with nanocurcumin; CHI, rats treated with nanochitosan; PDC, rats treated with potassium 
dichromate; CUR-PDC, rats treated nanocurcumin before potassium dichromate and; CHI-PDC, rats treated with nanochitosan before 
potassium dichromate 
Table 2: Number and percentage of sperm morphology abnormalities in of treated groups, one thousand sperm was examined in each 
animal, totally six thousand sperm examined per group 
Groups Normal 
sperms  















Control 5701 82 47 33 20 15 12 7 216 66 17 299 49.83± 
7.25 
4.98 
CUR 5645 119 65 39 30 27 13 6 299 52 4 355 59.17± 
2.86*  
5.92 
CHI 5694 109 77 40 27 19 10 9 291 14 1 306 51±2.61  5.1 
PDC 4208 694 179 78 52 40 35 11 1089 620 83 1792 298.67± 
7.26*  
29.87 
CUR+PDC 5070 367 155 81 50 65 29 12 759 138 33 930 155±3.74*#$ 15.5   
CHI+PDC 5292 283 129 66 39 46 27 8 598 96 14 708 118±4.52*#$ 11.8   
Data are expressed as mean±SD Statistical analysis was performed for statistical changes between the selected groups: *P ≤ 0.05 indicates statistical 
difference from the vehicle-treated (control) group, #P ≤ 0.05 indicates statistical difference from the PDC -treated group, and $P ≤ 0.05 indicates 
statistical difference between CHI+PDC and CUR+PDC groups in one-way ANOVA test with Tukey's multiple comparisons test. Abbreviations: hd= 
hook deformation, amr= amorphous, bh= big head, sh= small head, tri= triangular, 2h= two heads, col= collapsed, abnor= abnormalities. 
Mohamed et al. 
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There was no significant difference between CHI group and control 
group; meanwhile, a significant difference was observed in CUR 
group compared to the control group. Treatment with PDC resulted 
in significant increase in the incidence of sperm shape abnormalities. 
Data revealed that 1792 of the examined spermatozoa were 
damaged. Hook deformation was the most frequent type of head 
abnormalities which involved three types: acute curvature (the 
anterior tip of the sperm was acutely curved); deformed orientation 
(the anterior tip of the sperm was abnormally straight and showing 
less curvature); hookless (the lack of the anterior tip), fig. 3A. 
The remaining types of head abnormalities could be arranged in 
descending manner as follows: Amorphous head (irregular outline 
head that does not fit with any particular shape). Bighead (normal 
outline head with markedly bigger size than normal). Small head 
(normal outline head with a markedly smaller size than normal). 
Triangle head (head has three sides without hook). Two heads and 
collapsed head (curved down) were found to be less frequent. In 
normal conditions, the tail is long attached to the head at the base 
and extends with a continuous decreased in diameter. Meanwhile, 
after administration of PDC many deformities were seen in the form 
of forked tail, thin tail, and coiled tail. On the other hand, oral 
administration of nanoparticles of CUR or CHI before PDC 
significantly decreased the frequency of total sperm abnormalities 
(15.5% and 11.8%, respectively) compared with the PDC group 
(29.87%). The pre-treatment with CHI nanoparticles decreased total 




Fig. 3: Sperm morphology (A) Normal spermatozoa and different abnormalities in head, tail, or head and tail from treated groups. (B) 
Number of total abnormalities in the control and treated groups (n=6). Data are expressed as mean±SD Statistical analysis was performed 
for statistical changes between the selected groups: *P ≤ 0.05 indicates statistical difference from the vehicle-treated (control) group, #P ≤ 
0.05 indicates the statistical difference from the PDC-treated group, and $
 
P ≤ 0.05 indicates statistical difference between CHI+PDC and 
CUR+PDC groups in one-way ANOVA test with Tukey's multiple comparisons test 
Oxidative stress markers 
Normal levels of oxidative stress biomarkers were observed in the 
control group and in groups treated with CHI as well as CUR 
nanoparticles. On the other hand, renal and testicular GPx content 
was significantly reduced (61.4% and 50.7%, respectively) following 
PDC-administration, and a significant elevation of MDA content was 
detected in the kidney (47.7%) and testicular (75.4%) tissues. Also, 
PDC induced a significant elevation in renal MPO (327%). Treatment 
of animals with CHI or CUR nanoparticles, for 5 d prior to PDC 
injection significantly retrieved the altered levels of all oxidative 
stress biomarkers (fig. 4). 
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Fig. 4: Effects of nano CUR or nano CHI either alone or combined with PDC on the measured oxidative stress parameters [MDA level, GPx 
activity, and MPO activity] in the kidney of mice (upper raw), and the mice testicular MDA content, GPx activity, and testosterone level 
(lower raw). Data are expressed as mean±SD based on data from independent experiments performed in triplicate. *P ≤ 0.05 indicates 
statistical difference from the vehicle-treated (control) group, and #
 
P ≤ 0.05 indicates the statistical difference from the PDC-treated 
group in one-way ANOVA test with Tukey's multiple comparisons test 
Testicular testosterone  
Treatment with PDC significantly decreased testicular testosterone 
level by 64%, while both the CHI and CUR nanoparticles individually 
did not show any significant change as compared to the control. 
Pretreatment with either CUR nanoparticles (Group V) or CHI 
nanoparticles (Group VI) ameliorated the testicular testosterone 
level significantly as compared to the PDC-treated group (fig. 4). 
Western blot analysis of IL-18, IGF-1, caspase 3, and cytochrome 
c proteins 
Administration of CUR or CHI nanoparticles showed no effect on 
the normal expression levels of the measured proteins in the renal 
and testicular tissues of mice. Induction of renal injury in mice 
with PDC increased the normal kidney contents of IL-18 (115%), 
and IGF-1 (288%) significantly. Also, the PDC significantly 
increased the normal testis contents of caspase 3 (190%) and 
cytosolic cytochrome c (95%). Pretreatment of mice with CUR or 
CHI nanoparticles significantly decreased PDC-induced elevation 
renal contents of IL-18 and IGF-1 and testicular contents of 
caspase 3, with no significant difference between the effects of 
both doses of CUR and CHI nanoparticles. There was also a 
decrease in cytosolic cytochrome c of pretreated (CUR+PDC and 
CHI+PDC) groups compared to the PDC-treated group but was not 
significant (fig. 5). 
 
 
Fig. 5: Effects of nano CUR or nano CHI either alone or before PDC on testicular cytosolic cytochrome c (Cyt c) and caspase 3, and the renal 
interleukin-18 (IL-18) and insulin-like growth factor 1 (IGF-1) proteins. (A) Representative examples of a western blot images illustrating 
the cytosolic Cyt c and caspase 3 in the testicular homogenate of mice (left), and IL-18 and IGF-1 protein levels in total lysates samples 
from the kidney of mice (right). (B) Quantification of Cyt c and caspase 3 protein contents in the mice testis (upper), and IL-18 and IGF-1 
protein levels in mice kidney (lower), with each normalized to the corresponding β-Actin bands. The specific protein of the control group 
is set to 1.0, and all band intensities are shown as mean±SD based on data from independent experiments performed in triplicate. *P ≤ 
0.05 indicates statistical difference from the vehicle-treated (control) group and #P ≤ 0.05 indicates statistical difference from the PDC-
treated group in one-way ANOVA test with Tukey's multiple comparisons test 
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In recent years, enormous researches have focused on using 
nanoparticles as carrier molecules to allow nano-drugs to reach the 
chosen targets with the most efficacy and minimum toxic effects. 
These particles due to its smaller size, can be transported easily to 
different body organs via blood circulation [61, 62]. It was found 
that curcumin (CUR) nanoparticles possess more effectiveness than 
native CUR due to its particle size reduction [63]. Nano CUR has 
larger surface area so it may have a higher intracellular absorption 
capacity and higher systemic bioavailability in tissues compared to 
normal CUR [64]. Due to hydrophobic nature, CUR forming 
aggregates because of its low solubility in water; thus, CUR present 
inside the cytoplasm is very low while nano form dissolves 
completely in aqueous media, forming no aggregates due to the 
presence of zeta potential [65]. 
Chitosan (CHI) is affirmed as a nontoxic, biodegradable, and 
biocompatible compound according to FDA (Food and Drug 
Association) [66, 67]. Nano CHI have higher antimicrobial activities, 
antiviral, antifungal, antioxidant, and anti-inflammatory properties 
than CHI. Hence, nano CHI has the potential of becoming a powerful 
and safe natural promising candidate for therapeutic applications 
[68, 69]. In the present study, administration of potassium 
dichromate (PDC) caused a significant decrease in the important 
antioxidant enzyme GPx in mouse kidney tissues, which function to 
protect cells from oxidative damage and overproduction of ROS [70]. 
The PDC toxicity induced also a significant increase of oxidative 
stress MDA, which indicates that the antioxidant defense system 
failed to inhibit the formation of free radicals and the enhancement 
of lipid peroxidation, which lead to kidney injury. 
In addition, PDC induced a significant elevation in renal 
myeloperoxidase (MPO). Macrophages (neutrophils and monocytes) 
contain MPO, an enzyme that can cause tissue damage through 
formation of toxic reactive intermediates, such as hypochlorous acid 
(HOCl) out of hydrogen peroxide H2O2
On the other hand, pretreatment with nano CUR and nano CHI 
before PDC administration induced significant improvement in all 
biochemical parameters of the kidney. The results of Abd El-Rahman 
and Al-Jameel [50] declared that nano CUR is effective to protect 
against oxidative renal damage in male rats induced by cisplatin. 
Also, Ansar et al. [75] suggested that CUR nanoparticles exerted 
amelioration in the oxidative damage of renal tissue induced by lead 
in rats. The therapeutic effects of nano CUR are mediated through its 
antioxidant and anti-inflammatory properties. The study of Abdel-
Wahhab et al. [76] suggested that CHI nanoparticles singly or plus 
quercetin suppress the oxidative stress and renal genotoxicity of 
rats fed ochratoxin A-contaminated diet. 
 when released extracellularly 
[71]. MPO is associated in the pathogenesis of kidney diseases 
because both MPO and its products (HOCl, tyrosyl radical, and 
reactive nitrogen intermediates) have been demonstrated in renal 
tissue diseases [72, 73]. Meanwhile, intracellularly, MPO plays a 
major role in killing microbes but is released extracellularly at 
inflammatory sites after phagocyte activation and causes damage to 
host tissues [71, 74]. 
Our results also showed that PDC induced a statistically significant 
increase in the percentage of total chromosomal aberrations in the 
bone marrow. Chromosome aberrations assay from bone marrow 
cells is a sensitive cytogenetic technique for testing of the mutagenic 
and carcinogenic effects of environmental contaminants [77]. Cr 
(VI), once penetrate cells, produces free radicals during reduction to 
the chromium metabolites Cr (V), Cr (IV) and Cr (III), which can 
subsequently attack DNA leading to several forms of genotoxicity 
such as strand breakage, gene mutation, DNA fragmentation, 
chromosomal aberration, and micronuclei formation [78-80]. This 
indicates that free radicals-induced oxidative damage to DNA, could 
be a factor in mediating the cytogenetic changes in bone marrow 
cells [81]. This conclusion is in agreement with Dana Devi et al.; 
Patlolla et al.; Patlolla et al. and Cengiz et al. [82-85], which showed a 
pronounced DNA damage of PDC with the comet assay. 
Animals pretreated with nano CUR before PDC administration 
induced a significant improvement in chromosomal aberrations. The 
improving effect of nano CUR against PDC-induced cytogenetic 
toxicity may be attributed to its antioxidant activity, where CUR 
nanoparticles can lower ROS production, lipid peroxidation and 
augment the glutathione production [86, 87]. It also causes the 
production of O6-methylguanine-DNA methyltransferase, which is a 
protein required for cellular genome protection [88, 89]. Our results 
are in consent with those of Sankar et al. and Yadav et al. [81, 61]. 
Sankar et al. explored that nanoformulation of CUR have better 
protective effect than free CUR against arsenic-induced genotoxicity 
in bone marrow cells of rats including chromosomal aberrations, 
micronuclei formation and comet DNA damage. While Yadav et al. 
investigated the preventive potency of nano CUR in mitigating 
effects of arsenic and fluoride, which resulted in lowering of ROS and 
restoration of blood glutathione level altered by arsenic and fluoride.  
The results also detected that mice pretreated with nano CHI 
exhibits significant protection against PDC induced chromosomal 
aberrations, likely through its free-radical scavenging activity, 
preventing oxidative stress and the DNA from damage. These 
findings are in agree with the previous results of Abdel-Wahhab et 
al. [76, 90]. They found that CHI nanoparticles modulate GPx gene 
expression and prevent the genotoxicity of aflatoxin B1 in rat liver 
through decreasing liver genomic DNA fragmentation as well as 
MDA level. In addition, they revealed that CHI nanoparticles protect 
against the nephrotoxicity of ochratoxin and succeeded to mitigation 
these toxic effects through free radical scavenging properties, 
enhancement of the antioxidant capacity of quercetin, improvement 
in DNA fragmentation and improvement in GPx mRNA expression. 
The present findings also demonstrated that the administration of PDC 
to mice resulted in a significant decline in the testicular testosterone 
levels and a decline in testicular antioxidant marker GPx, as well as a 
significant increase in the abnormal sperm morphology and a 
significant increase in testicular oxidative stress MDA which indicates 
that PDC is a male reproductive toxicant. These results were 
supported by the Oliveira et al. [91] who evaluated the effects of PDC 
on mouse sperm cells after short-term exposure. Their results showed 
an increase in the percentage of multiple abnormalities, a decrease in 
the percentage of normal spermatozoa, a decrease in spermatozoa 
motility, and a decrease in acrosome integrity. Furthermore, Bashandy 
et al. [92] found that PDC induced testicular lesions and alteration in 
testosterone level, which may lead to a spermatogenic arrest as 
appeared from reducing epididymal sperm number and increase of 
sperm abnormalities. The mechanism of reproductive deterioration by 
PDC might be associated with oxidative stress and disruption of the 
hypothalamic-pituitary-testicular feedback. Male germ cells and 
spermatozoa, because their membranes contain a high percentage of 
fatty acids, are more susceptible to oxidative stress than somatic cells. 
Oxidative stress considered a main agent in infertility, lead to sperm 
damage and deformity [93, 94].  
On the other hand, our study showed that in the groups that 
pretreated with CUR or CHI nanoparticles before PDC, there was a 
significant reduction in the sperm abnormality and the testicular 
testosterone concentration was significantly raised and restored to 
its normal levels. The pretreatment with the two nanoparticles also 
significantly decreased MDA levels and increased the activity of GPx 
levels, owing to their potent antioxidant activity and free radical 
scavenger potential, which can decrease the lipid peroxidation (MDA 
level). The decrease in lipid peroxidation can increase the 
antioxidant defense system such as GPx, which protect against free 
radical attack and thus protect PDC-induced testis damage. In 
agreement to our results, Ahmed-Farid et al. [95] showed that 
administration of CUR nano-encapsulation as a daily supplement 
improved the spermatogenesis defects induced by malnutrition-
treated rats. Also, Sudjarwo et al. [96] found that CHI nanoparticle 
could protects rat testis from oxidative damage and apoptosis 
caused by lead acetate, through increasing antioxidants and 
inhibiting caspase 3 expression. 
Induction of renal injury in mice by PDC in the present study 
resulted in a significant elevation in the expression of Interleukin-18 
(IL-18) and insulin-like growth factor-1 (IGF-1) contents of the 
kidney. IL-18 is a pro-inflammatory cytokine that play an important 
role in renal injury and a potential mediator of tubular damage [97, 
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98]. Also, the elevation of renal content of IGF-1 might contribute to 
the progression of PDC-induced chronic renal injury [99]. These 
results are in agree with those of Hegazy et al. [51], which revealed 
that PDC-induced acute nephrotoxicity and the involvement of IL-18 
in the renal tissue damage and tubular injury induced by PDC. 
Moreover, IGF-1 also play an important role in the pathogenic renal 
tissue hypertrophy in PDC-acute nephrotoxicity. Pretreatment with 
CUR and CHI nanoparticles before PDC markedly decreased the 
renal contents of IL-18 and IGF-1 compared to the PDC-treated 
group. These observations documented that nanoparticles showed 
anti-inflammatory activity. That agrees with the previous findings 
that have confirmed that nanoparticles of CHI and CUR alone or in 
combination with hydroxyapatite nanoparticles significantly 
minimized the levels of inflammatory cytokines: TNF-α and IL-6 in 
kidney tissues of male rats [100]. 
The PDC administration also significantly upregulated the testicular 
caspase-3 and cytosolic cytochrome c expressions at protein levels, 
compared to control animals which is indicative of spermatogenic 
cell apoptosis. The caspase-3 activates cytoplasmic endonucleases 
that degrade the nuclear materials and proteins as well as 
cytoskeletal proteins [101, 102], which adversely impact 
spermatogenesis process. The mitochondrial dysfunction (increased 
the permeability of mitochondrial membrane) induced by oxidative 
stress can lead to the release of cytochrome c from mitochondria to 
the cytosol and then caspase activation, which results in apoptotic 
cell death [103]. 
On the other hand, CUR and CHI nanoparticles prior to PDC 
significantly decreased the upregulation of the testicular caspase-3 
induced by PDC. They also decreased the upregulation of the 
testicular cytochrome c but it was non-significant when compared to 
the PDC-treated group. This supports the anti-apoptotic action of 
nanoparticles in PDC-stimulated germ cell apoptosis. The 
anti-apoptotic action may involve regulation of pro-and 
anti-apoptotic proteins, the release of mitochondrial cytochrome c 
and activation of caspase-dependent cell death pathways. Taba et al. 
[104] showed that CUR administration causes a reduction in tunnel 
positive apoptotic cells as well as an alleviation in biochemical 
markers and sperm parameters in the testicular tissue of the aging 
mouse model. Furthermore, the investigation of Zalok et al. [105] 
showed that co-administration of CHI nanoparticles with cimetidine 
resulted in the weak immune response against caspase 3 in the 
seminiferous tubules of mouse testicular tissues. 
CONCLUSION 
Potassium dichromate resulted significantly in cytotoxic and 
cytogenetic effects as indicated by changes in the biochemical 
parameters, protein expression of kidney and testis, structure and 
number of chromosomes and sperm morphology in mice. Protection 
with nanoparticles of curcumin and chitosan are significantly able to 
alleviate these toxic effects through by enhancement of antioxidant 
capacity, reduction of oxidative stress, chromosomal aberrations and 
sperm abnormalities as well as regulation of expression of 
inflammatory cytokines and apoptotic proteins. Moreover, chitosan 
nanoparticles were found significantly more effective than curcumin 
nanoparticles in reducing chromosomal aberrations and sperm 
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